NCT07140679
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07140679
Title Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Emory University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Emory Decatur Hospital RECRUITING Atlanta Georgia 30033 United States Details
Emory University Hospital Midtown RECRUITING Atlanta Georgia 30308 United States Details
Emory University Hospital/Winship Cancer Institute RECRUITING Atlanta Georgia 30322 United States Details
Emory Saint Joseph's Hospital RECRUITING Atlanta Georgia 30342 United States Details
Emory Johns Creek Hospital RECRUITING Johns Creek Georgia 30097 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field